As a the world continues to battle this virus, much hope is focused on a “silver bullet” vaccine. But as nations rush to deliver protection, questions continue to arise on efficacy, safety, and deployment. The anxiety over these decisions, for some, rivals the anxiety over the virus itself. The more information released, the more we are being asked to absorb, and the more the confusion grows!
On the same day that Pfizer and BioNTech released blockbuster results from the Phase III trial of their COVID-19 vaccine, Brazil threw a wrench into the plans of one of China’s most promising coronavirus vaccine candidates.